Alexion Pharmaceuticals Inc (ALXN) $103.40 +4.13%
Biotech Alexion Pharma shares are near $103 after setting a new 52wk high a few minutes ago and option flow is heavy and defensive, with buyers of downside Aug 90 puts hitting the market earlier today when shares were near 102.40. More than 2000 contracts have traded so far, at an avg px of 2.19, and the buyer may be looking to hedge the $20 handle climb in shares since mid-May.
Category: All Stocks, Large Cap Stocks, Pharmaceuticals & Biotechnology
Free Newsletter
If you enjoyed this article, sign up to receive more just like it.
About the Author (Author Profile)
Henry Schwartz is the president of Trade Alert LLC, a provider of real-time options analysis tools to leading Wall Street firms. His systems analyze hundreds of thousands of transactions per second to help professionals identify and interpret market activity in real time, supporting informed trading decisions and intelligent idea generation. He has held institutional trading and management roles with Bank of America, Bear Stearns, Salomon Brothers and the Hull Group, and made markets on the CBOE and AMEX floors in the US, and EUREX and MONEP overseas. Prior to founding Trade Alert, he led the electronic market-making group at Bank of America coincident with the launch of the International Securities Exchange. He received his bachelor’s degree in Economics from the University of California, San Diego and his MBA from NYU’s Stern School of Business.
